OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
FDA issues a notice requiring the manufacturers of 25 high-risk drugs and biologics to submit a REMS plan.
In a notice published in the March 27